Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
boston
boston blog main
boston top stories
national top stories
san diego blog main
science
ally bridge group
alnylam
arena pharmaceuticals
artie suckow
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
big data analytics
biology
blackrock
bluebird bio
cancer
casdin capital
diabetic nephropathy
drug delivery
dtx pharma
duchenne muscular dystrophy
dyne therapeutics
eventide asset management
facioscapulohumeral muscular dystrophy
financing
focal segmental glomerulosclerosis
gene therapy
goldfinch bio
irving investors
jay ghosh
jeff friedman
john grundy
joshua brumm
What
diseases
5
×
medicines
5
×
new
company
developing
drug
genetic
ipo
raises
rna
treat
addition
advance
ago
alltrna
analysis
announced
assess
based
betting
bio
biologics
biotech
biotechs
bring
called
certain
companies
considered
considering
curious
data
day
deliver
develop
dna
drugs
dtx
dyne
early
Language
unset
5
×
Current search:
medicines
×
diseases
×
unset
×
@wired.com
7 months ago
Everything You Need to Know About Getting Your Genome Sequenced
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs